• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? PRO; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX? PRO; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635WU60400
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pericardial Effusion (3271)
Date of Event 03/12/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that there was a pericardial effusion.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) and a 40mm watchman flx pro laa closure device & delivery system (wds) were selected to be used.The physician positioned the was in the laa of the patient and then inserted the wds.The closure device was deployed and recaptured four (4) times, but the closure device did not meet release criteria.The physician exchanged the was for a trusteer was and a new 40mm wds.The physician positioned the new was in the laa of the patient and then inserted the new wds.The closure device was deployed twice and met all release criteria.The closure device was successfully implanted in the laa of the patient.During the check of the laa a trace to mild pericardial effusion was noted.The patient remained hemodynamically stable and no intervention or treatment was required.The physician planned to perform a transthoracic echocardiogram prior to discharge.The patient is expected to make a full recovery from this event and will be discharged from the hospital.
 
Event or Problem Description
It was reported that there was a pericardial effusion.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) and a 40mm watchman flx pro laa closure device & delivery system (wds) were selected to be used.The physician positioned the was in the laa of the patient and then inserted the wds.The closure device was deployed and recaptured four (4) times, but the closure device did not meet release criteria.The physician exchanged the was for a trusteer was and a new 40mm wds.The physician positioned the new was in the laa of the patient and then inserted the new wds.The closure device was deployed twice and met all release criteria.The closure device was successfully implanted in the laa of the patient.During the check of the laa a trace to mild pericardial effusion was noted.The patient remained hemodynamically stable and no intervention or treatment was required.The physician planned to perform a transthoracic echocardiogram prior to discharge.The patient is expected to make a full recovery from this event and will be discharged from the hospital.
 
Additional Manufacturer Narrative
The device was not returned for analysis as the device remains implanted; therefore, a technical analysis could not be performed.It was confirmed this device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX? PRO
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key24622726
Report Number2124215-2026-14785
Device Sequence Number8698340
Product Code NGV
UDI-Device Identifier00191506004637
UDI-Public(01)00191506004637(17)270918(10)34877164
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberM635WU60400
Device Catalogue NumberM635WU60400
Device Lot Number0034877164
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2026
Supplement Date Received by Manufacturer04/09/2026
Initial Report FDA Received Date03/17/2026
Supplement Report FDA Received Date04/14/2026
Date Device Manufactured09/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age72 YR
Patient SexMale
Patient RaceWhite
-
-